Hunter Hall Managed Fund would be great to get involved as an activist SH. Sirtex has less growth options with a part fail on FDA trials, cashed up, big cap, experienced in bringing products through approval to sale. Other Australian Biotechs.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
